| Document and Entity Information | 6 Months Ended |
| Dec. 31, 2015shares | |
| Document and Entity Information [Abstract] | |
| Document Type | 10-Q |
| Amendment Flag | false |
| Document Period End Date | Dec. 31, 2015 |
| Document Fiscal Year Focus | 2,016 |
| Document Fiscal Period Focus | Q2 |
| Entity Registrant Name | Green Meadow Products, Inc. |
| Entity Central Index Key | 1,557,340 |
| Current Fiscal Year End Date | --06-30 |
| Entity Filer Category | Smaller Reporting Company |
| Entity Common Stock, Shares Outstanding | 52,944,500 |
| CONDENSED BALANCE SHEETS - USD ($) | Dec. 31, 2015 | Jun. 30, 2015 |
| Current Assets | ||
| Cash | $ 19,046 | $ 33,162 |
| Income tax benefit | 2,346 | |
| Total Current Assets | 21,392 | 33,162 |
| Other Assets | ||
| Web development costs, net of amortization of $1,500 and $2,500 respectively | 11,000 | 12,500 |
| Other intangible assets, net of amortization of $538 and $2,452 respectively | 7,760 | 8,298 |
| Total Assets | 40,152 | 53,960 |
| Current Liabilities | ||
| Accounts Payable | 0 | 298 |
| Income tax | 0 | 32 |
| Total Current Liabilities | 0 | 330 |
| Total Liabilities | 0 | 330 |
| Stockholders' Equity | ||
| Common stock $0.001 par value 75,000,000 shares authorized 52,944,500 shares issued and outstanding at December 31, 2015 (unaudited) and June 30, 2015 | 52,945 | 52,945 |
| Additional paid-in-capital | 505 | 505 |
| Accumulated Earnings | (13,298) | 180 |
| Total Stockholders' Equity | 40,152 | 53,630 |
| Total Liabilities and Stockholders' Equity | $ 40,152 | $ 53,960 |
| CONDENSED BALANCE SHEETS (Parenthetical) - USD ($) | Dec. 31, 2015 | Jun. 30, 2015 |
| Statement of Financial Position [Abstract] | ||
| Accumulated Amortization - Web Development Costs | $ 1,500 | $ 2,500 |
| Accumulated Amortization - Other Intangible Assets | $ 538 | $ 2,452 |
| Common stock par value | $ 0.001 | $ 0.001 |
| Common stock shares authorized | 75,000,000 | 75,000,000 |
| Common stock shares issued | 52,944,500 | 52,944,500 |
| Common stock shares outstanding | 52,944,500 | 52,944,500 |
| CONDENSED STATEMENTS OF OPERATIONS - USD ($) | 3 Months Ended | 6 Months Ended | ||
| Dec. 31, 2015 | Dec. 31, 2014 | Dec. 31, 2015 | Dec. 31, 2014 | |
| Revenue | ||||
| Pet Products | $ 3,360 | |||
| Sub license agreements | $ 10,000 | $ 0 | 15,000 | $ 15,000 |
| Total Revenue | 10,000 | 0 | 18,360 | 15,000 |
| Cost of goods sold | 0 | 0 | 2,000 | 0 |
| Gross Profit | 10,000 | 0 | 16,360 | 15,000 |
| Operating Expenses | ||||
| Professional fees | 18,499 | 3,000 | 29,397 | 19,000 |
| Amortization | 1,019 | 624 | 2,038 | 922 |
| Marketing | 0 | 7,000 | 0 | 7,000 |
| General & Administrative | 530 | 6 | 781 | 12 |
| Total Operating Expenses | 20,048 | 10,630 | 32,216 | 26,934 |
| Income (loss) before income taxes | (10,048) | (10,630) | (15,856) | (11,934) |
| Income taxes (benefit) | (1,507) | (1,594) | (2,378) | (1,790) |
| Net Income (loss) | $ (8,541) | $ (9,036) | $ (13,478) | $ (10,144) |
| Basic and Diluted Income (Loss) Per Share from operations | $ 0 | $ 0 | $ 0 | $ 0 |
| Weighted Average of Common Shares Outstanding basic and diluted | 52,944,500 | 52,944,500 | 52,944,500 | 52,944,500 |
| CONDENSED STATEMENT OF CASH FLOWS - USD ($) | 6 Months Ended | |
| Dec. 31, 2015 | Dec. 31, 2014 | |
| Cash Flows from Operating Activities | ||
| Net Income (loss) | $ (13,478) | $ (10,144) |
| Adjustments to Reconcile Net Income (Loss) To Net Cash Provided by (Used In) Operating Activities: | ||
| Amortization expense | 2,038 | 922 |
| Changes in operating assets and liabilities | ||
| Accounts Receivable | (5,000) | |
| Accounts Payable | (298) | |
| Deferred Revenue | 0 | 15,000 |
| Income Tax Payable/Receivable | (2,378) | (1,790) |
| Net Cash Provided by (used in) Operating Activities | (14,116) | (1,012) |
| Cash Flows from Investing Activities | ||
| Website development costs | 0 | (5,000) |
| Net Cash used in Investing Activities | 0 | (5,000) |
| Net Cash Provided by (Used in) Financing Activities | ||
| Increase (decrease) in Cash | (14,116) | (6,012) |
| Cash at Beginning of Period | 33,162 | 47,713 |
| Cash at End of Period | $ 19,046 | $ 41,701 |
| NATURE OF OPERATIONS | 6 Months Ended |
| Dec. 31, 2015 | |
| NATURE OF OPERATIONS [Abstract] | |
| NATURE OF OPERATIONS | Note 1 - NATURE OF OPERATIONS Green Meadow Products, Inc. ("the Company", "GMP", "we", "us" or "our") was incorporated under the laws of the State of Wyoming on June 22, 2012. The Company initially acquired a product for trucking fleets on December 20, 2012. Subsequently on April 18, 2013, we made the decision to take the business in a different direction and sold the product for the trucking fleets at a loss. The Company's current focus is on the sales of licensing rights to our Green Meadow PR formula and the manufacturing and sales of our Green Meadow PR formula as well as the manufacturing and sales of our PawPal product and our recently acquired stress relief formula. |
| SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 6 Months Ended |
| Dec. 31, 2015 | |
| Significant Accounting Policies (Policies) [Abstract] | |
| SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | Note 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES A summary of the significant accounting policies applied in the preparation of the accompanying financial statements follows. BASIS OF PRESENTATION The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. They do not include all information and footnotes necessary for a fair presentation of financial position, results of operations and cash flows in conformity with U.S. GAAP for complete financial statements. Certain information and note disclosures normally included in audited financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading. In the opinion of management, all adjustments (consisting of normal recurring adjustments and accruals) considered necessary for a fair presentation of the results of operations for the period presented have been included in the interim period. The operating results for the three and six-month period ended December 31, 2015 are not necessarily indicative of the results to be expected for the entire year ending June 30, 2016 or for any future period. These unaudited condensed financial statements and notes should be read in conjunction with the financial statements and related notes contained in the Company's Annual Report on Form 10-K for the year ended June 30, 2015. RECLASSIFICATION Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations 6 CUSTOMER AND PURCHASE CONCENTRATION During the quarter ended December 31, 2015 we had a referral fee for sub license agreement of the Green Meadow Pain Formula of $10,000 which accounted for 100% of our revenue; During the six months ended December 31, 2015 we had sales of $18,360 from three customers; one customer for $10,000 which equates to 55% of sales, one customer for $5,000 which equates to 27% of sales and one for $3,360 which equates to 18% of sales. During the quarter ended December 31, 2014 we $0 in sales and for the six months ended December 31, 2014 we had $15,000 in sales to one customer for licensing rights which accounted for 100% of revenue for the six month period. NET INCOME (LOSS) PER SHARE OF COMMON STOCK The Company computes net income (loss) per share in accordance with ASC 105, "Earnings per Share" which requires presentation of both basic and diluted earnings per share on the face of the statement of operations. Basic income (loss) per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted loss per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive. The Company has no potentially dilutive debt or equity instruments issued and outstanding during the quarters ended December 31, 2015 or 2014. RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on our financial condition or the results of its operations other than in respect of the early adoption of the new regulations relating to Development Stage Entities as discussed above. |
| GOING CONCERN | 6 Months Ended |
| Dec. 31, 2015 | |
| GOING CONCERN [Abstract] | |
| GOING CONCERN | Note 3- GOING CONCERN The financial statements have been prepared on a going concern basis which assumes the Company will be able to realize its assets and discharge its liabilities in the normal course of business for the foreseeable future. As at December 31, 2015 the Company had yet to establish a proven, reliable, recurring source of revenue to fund its ongoing operating costs and with insufficient funds to fully implement its proposed business plan. This raises substantial doubt about the Company's ability to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations. In order to continue as a going concern, the Company will need, among other things, additional capital resources. The Company is contemplating conducting an offering of its debt or equity securities to obtain additional operating capital. The Company is dependent upon its ability, and will continue to attempt, to secure equity and/or debt financing. There are no assurances that the Company will be successful and without sufficient financing it would be unlikely for the Company to continue as a going concern. |
| SUBSEQUENT EVENTS | 6 Months Ended |
| Dec. 31, 2015 | |
| SUBSEQUENT EVENTS [Abstract] | |
| SUBSEQUENT EVENTS | Note 4 - SUBSEQUENT EVENTS Management has reviewed events between December 31, 2015 to the date that the financials were issued, and there were no significant events identified for disclosure. 7 |
| Significant Accounting Policies (Policies) | 6 Months Ended |
| Dec. 31, 2015 | |
| Significant Accounting Policies (Policies) [Abstract] | |
| ACCOUNTING POLICIES | A summary of the significant accounting policies applied in the preparation of the accompanying financial statements follows. |
| BASIS OF PRESENTATION | BASIS OF PRESENTATION The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America for interim financial information and the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. They do not include all information and footnotes necessary for a fair presentation of financial position, results of operations and cash flows in conformity with U.S. GAAP for complete financial statements. Certain information and note disclosures normally included in audited financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading. In the opinion of management, all adjustments (consisting of normal recurring adjustments and accruals) considered necessary for a fair presentation of the results of operations for the period presented have been included in the interim period. The operating results for the three and six-month period ended December 31, 2015 are not necessarily indicative of the results to be expected for the entire year ending June 30, 2016 or for any future period. These unaudited condensed financial statements and notes should be read in conjunction with the financial statements and related notes contained in the Company's Annual Report on Form 10-K for the year ended June 30, 2015. |
| RECLASSIFICATION | RECLASSIFICATION Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations 6 |
| CUSTOMER AND PURCHASE CONCENTRATION | CUSTOMER AND PURCHASE CONCENTRATION During the quarter ended December 31, 2015 we had a referral fee for sub license agreement of the Green Meadow Pain Formula of $10,000 which accounted for 100% of our revenue; During the six months ended December 31, 2015 we had sales of $18,360 from three customers; one customer for $10,000 which equates to 55% of sales, one customer for $5,000 which equates to 27% of sales and one for $3,360 which equates to 18% of sales. During the quarter ended December 31, 2014 we $0 in sales and for the six months ended December 31, 2014 we had $15,000 in sales to one customer for licensing rights which accounted for 100% of revenue for the six month period. |
| NET INCOME (LOSS) PER SHARE OF COMMON STOCK | NET INCOME (LOSS) PER SHARE OF COMMON STOCK The Company computes net income (loss) per share in accordance with ASC 105, "Earnings per Share" which requires presentation of both basic and diluted earnings per share on the face of the statement of operations. Basic income (loss) per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted loss per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive. The Company has no potentially dilutive debt or equity instruments issued and outstanding during the quarters ended December 31, 2015 or 2014. |
| RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS | RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on our financial condition or the results of its operations other than in respect of the early adoption of the new regulations relating to Development Stage Entities as discussed above. |
| SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Text) - USD ($) | 3 Months Ended | 6 Months Ended | ||
| Dec. 31, 2015 | Dec. 31, 2014 | Dec. 31, 2015 | Dec. 31, 2014 | |
| SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract] | ||||
| Referral fee for sub license agreement of Green Meadow Pain Formula | $ 10,000 | $ 0 | ||
| Green Madow Pain Formula's percent of revenue | 100.00% | 100.00% | ||
| Sales | $ 10,000 | $ 0 | $ 18,360 | $ 15,000 |
| Total | ||||
| SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract] | ||||
| Sales | 18,360 | $ 15,000 | ||
| Customer One | ||||
| SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract] | ||||
| Sales | $ 10,000 | |||
| Percent of sales | 55.00% | |||
| Customer Two | ||||
| SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract] | ||||
| Sales | $ 5,000 | |||
| Percent of sales | 27.00% | |||
| Customer Three | ||||
| SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract] | ||||
| Sales | $ 3,360 | |||
| Percent of sales | 18.00% | |||
